The Patent Finder

Ojai Retinal Technology, LLC

32 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for System for neuroprotective therapy for glaucoma (US 10,299,961) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 2 fees due Dec 4 to 20, 2026 · next Dec 4
  • 2 fees due Jan 23 to 30, 2027 · next Jan 23
  • 2 fees due Apr 8 to 27, 2027 · next Apr 8
  • 1 fee due Jul 14, 2027
    The maintenance fee for Method for heat treating biological tissues using pulsed energy sources (US 10,531,908) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Process and system for utilizing energy to treat biological tissue (US 10,596,389) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,168,174Process for restoring responsiveness to medication in tissue of living organisms
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,381,116Subthreshold micropulse laser prophylactic treatment for chronic progressive retinal diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,427,602Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,962,291System and process for neuroprotective therapy for glaucoma
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,238,542System and Process for Retina Phototherapy
In force
 · Medium confidence
In forceMedium confidence
US 10,278,865Process for Neuroprotective Therapy for Glaucoma
In force
 · Low confidence
In forceLow confidence
US 10,285,859System for performing retina photostimulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,299,961System for neuroprotective therapy for glaucoma
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,307,294System and process for neuroprotective therapy for glaucoma
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,363,171System and process for retina phototherapy
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 32 patents shown.
Pro members see all 32.
Pro members: see all 32 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited